• English
    • Welsh
  • English 
    • English
    • Welsh
  • Login
Search DSpace:
  • Home
  • Research at Cardiff Met
  • Library Services
  • Contact Us
View item 
  • DSpace home
  • Cardiff School of Sport and Health Sciences
  • Health and Risk Management
  • View item
  • DSpace home
  • Cardiff School of Sport and Health Sciences
  • Health and Risk Management
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Increased levels of soluble Receptor for Advanced Glycation End-Products (RAGE) are associated with a higher risk of mortality in frail older adults

Thumbnail
View/open
Author's post-print (859.3Kb)
Author
Butcher, Lee
Carnicero, Jose
Gomez-Cabrero, David
Dartigues, Jean-Francois
Peres, Karine
Garcia-Garcia, Francisco Jose
Rodriguez-Mañas, Leocadio
Erusalimsky, Jorge
Date
2019-06-18
Acceptance date
2019-05-24
Date Accepted
2019-05-29
Type
Article
acceptedVersion
Publisher
Oxford University Press
ISSN
1468-2834
Metadata
Show full item record
Abstract
Objective: To evaluate the relationship between serum levels of the soluble Receptor for Advanced Glycation End-products (sRAGE) and mortality in frail and non-frail older adults. Methods: We studied 691 subjects (141 frail and 550 non-frail) with a median age of 75 years from two population-based cohorts, the Toledo Study of Healthy Aging and the AMI study, who were enrolled to the FRAILOMIC initiative. Multivariate Cox proportional hazards regression and Kaplan-Meier survival analysis were used to assess the relationship between baseline sRAGE and mortality. Results: During 6 years of follow-up 101 participants died (50 frail and 51 non-frail). Frail individuals who died had significantly higher sRAGE levels than those who survived (median [IQR]: 1563 [1015-2248] vs 1184 [870-1657] pg/mL, P=0.006), whilst no differences were observed in the non-frail group (1262 [1056-1554] vs 1186 [919-1551] pg/mL, P=0.19). Among frail individuals higher sRAGE levels were associated with an increased risk of death after adjustment for relevant covariates (HR=2.72 per unit increment in ln-sRAGE, 95%CI 1.48-4.99, P=0.001). In contrast, in non-frail individuals sRAGE showed no association with mortality. Survival curves demonstrated that among frail individuals the incidence of death was significantly higher in the top sRAGE quartile compared to the three lower quartiles (P=0.002). Area under the ROC curve analysis demonstrated that for frail individuals, inclusion of sRAGE in the hazard model increased its predictive accuracy by ~3%. Conclusions: sRAGE is an independent predictor of mortality among frail individuals. Determination of sRAGE in frail subjects could be useful for prognostic assessment and treatment stratification.
Journal/conference proceeding
Age and Ageing;
URI
http://hdl.handle.net/10369/10534
DOI
http://dx.doi.org/10.1093/ageing/afz073
Description
Article published in Age and Ageing on 18 June 2019, available at: https://doi.org/10.1093/ageing/afz073.
Rights
http://www.rioxx.net/licenses/all-rights-reserved
Sponsorship
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
The FRAILOMIC study was supported by the European Union Seventh Framework Programme under grant agreement number 305483.
The AMI project was funded by AGRICA (CAMARCA, CRCCA, CCPMA PREVOYANCE, CPCEA, AGRI PREVOYANCE), la Mutualité Sociale Agricole (MSA) de Gironde, la Caisse Centrale de la Mutualité Sociale Agricole (CCMSA).
Collections
  • Health and Risk Management [392]

Related items

Showing items related by title, author, subject and abstract.

  • Thumbnail

    Higher sRAGE levels predict mortality in frail older adults with cardiovascular disease 

    Butcher, Lee; Carnicero, Jose Antonio; Peres, Karine; Colpo, Marco; Gomez-Cabrero, David; Dartigues, Jean-François; Bandinelli, Stefania; Garcia-Garcia, Francisco Jose; Manas, Leocadio Rodriguez; Erusalimsky, Jorge (Karger, 2021-01-21)
    Introduction: The evidence that blood levels of the soluble receptor for advanced glycation end products (sRAGE) predict mortality in people with cardiovascular diseases (CVD) is inconsistent. To clarify this matter, we ...
  • Thumbnail

    A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts 

    Gomez-Cabrero, David; Walter, S.; Abugessaisa, I.; Miñambres-Herraiz, R.; Palomares, L.B.; Butcher, Lee; Erusalimsky, Jorge; Garcia-Garcia, F.J.; Carnicero, J.; Hardman, T.C.; Mischak, H.; Zürbig, P.; Hackl, M.; Grillari, J.; Fiorillo, E.; Cucca, F.; Cesari, M.; Carrie, I.; Colpo, M.; Bandinelli, S.; Feart, C.; Peres, K.; Dartigues, J-F; Helmer, C.; Viña, J.; Olaso, G.; García-Palmero, I.; Martínez, J. G.; Jansen-Dürr, P.; Grune, T.; Weber, D.; Lippi, G.; Bonaguri, C.; Sinclair, A. J.; Tegner, J.; Rodriguez-Mañas, L.; on behalf of the FRAILOMIC initiative (Springer, 2021-02-18)
    Phenotype-specific omic expression patterns in people with frailty could provide invaluable insight into the underlying multi-systemic pathological processes and targets for intervention. Classical approaches to frailty ...
  • Thumbnail

    'In search of ‘Omics'-based biomarkers to predict risk of frailty and its consequences in older individuals: the FRAILOMIC initiative 

    Erusalimsky, Jorge; Grillari, Johannes; Grune, Tilman; Jansen-Duerr, Pidder; Lippi, Giuseppe; Sinclair, Alan; Tegner, Jesper; Vina, Jose; Durrance-Bagale, Anna; Minambres, Rebecca; Viegas, Marcelo; Rodriguez-Manas, Leocadio (Karger, 2016)
    An increase in the number of older people experiencing disability and dependence is a critical aspect of the demographic change that will emerge within Europe due to the rise in life expectancy. In this scenario, prevention ...

Browse

DSpace at Cardiff MetCommunities & CollectionsBy issue dateAuthorsTitlesSubjectsThis collectionBy issue dateAuthorsTitlesSubjects

My Account

Login

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

DSpace software copyright © 2002-2015  DuraSpace
Contact us | Send feedback | Administrator